A carregar...
Left Atrial Thrombosis Despite Dabigatran Therapy
Dabigatran is a novel anticoagulation which has been approved as an alternative to warfarin therapy for non-valvular atrial fibrillation. Use of Dabigatran for approved indications as well as off label use has dramatically increased after Federal Drug Administration (FDA) approval. Our patient had l...
Na minha lista:
| Publicado no: | J Atr Fibrillation |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cardiofront, Inc
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5153238/ https://ncbi.nlm.nih.gov/pubmed/28496880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.891 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|